Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 10/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.36 |
| ▸ | PSMB9 | P28065 | 6/20 | 0.36 |
| ▸ | PPIA | P62937 | 2/20 | 0.36 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.35 |
| ▸ | TERF2 | Q15554 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16938900 | 0.93 | FAP (0.37) | HDAC1HDAC4HDAC6HDAC3 | |
| SCHEMBL16938957 | 0.83 | MMP3 (0.42) | HDAC1HDAC4PSMB9PPIAPSMB8 | |
| SCHEMBL16938906 | 0.83 | HDAC1 (0.36) | HDAC1HDAC4HDAC6HDAC3 | |
| SCHEMBL16938903 | 0.75 | HDAC1 (0.38) | HDAC1HDAC4HDAC6HDAC3 | |
| SCHEMBL16938953 | 0.73 | GAA (0.33) | HDAC1HDAC4HDAC6 | |
| SCHEMBL16938905 | 0.70 | TERF2 (0.35) | HDAC1HDAC4HDAC6TERF2 | |
| SCHEMBL16938890 | 0.70 | FAP (0.32) | HDAC1HDAC4HDAC6 | |
| SCHEMBL16938907 | 0.70 | FAP (0.32) | HDAC1HDAC4HDAC6 | |
| SCHEMBL16938908 | 0.70 | TSHR (0.34) | HDAC1HDAC4HDAC6HDAC3 | |
| SCHEMBL16938911 | 0.69 | HDAC4 (0.31) | HDAC1HDAC4HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2364310-B1 | 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION | ACHILLION PHARMACEUTICALS INC (US) | 2015-07-29 | — | — | EP | disclosed |